Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction
| Autor: | L A, Labbate, J B, Grimes, A, Hines, M H, Pollack |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Adult
Male Mood Disorders Libido Sexual Behavior Middle Aged Anxiety Disorders Antidepressive Agents Paroxetine 1-Naphthylamine Treatment Outcome Fluoxetine Sertraline Antidepressive Agents Second-Generation Humans Drug Therapy Combination Female Sexual Dysfunctions Psychological Bupropion Selective Serotonin Reuptake Inhibitors Pain Measurement |
| Zdroj: | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 9(4) |
| ISSN: | 1040-1237 |
| Popis: | Serotonin reuptake inhibitor (SRI)-induced sexual dysfunction is common, and a number of pharmacologic adjunctive strategies have been employed to treat this vexing problem. This open label study tested the efficacy of adjunctive bupropion across several measures of sexual function. Patients taking SRIs for various mood or anxiety disorders who reported prospective decline in sexual function after at least 2 months on SRIs were offered treatment with bupropion, 75 mg/day. Eight patients were treated, and sexual function was measured by use of a visual analog scale at 1 month of treatment. Four of eight patients experienced marked improvement in sexual dysfunction following adjunctive bupropion treatment. Bupropion may be a pharmacologic option for treating SRI-associated sexual dysfunction, though controlled clinical trials are needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink